Skip to main content

Advertisement

Table 1 Patients and tumor characteristics (n = 23)

From: High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma

Variable Value (%)
Age at diagnosis (yr)
 Median 67.0
 Range 38–78
Gender
 Male 11 (47.8)
 Female 12 (52.2)
Tumor location
 Head 21 (91.3)
 Body 1 (4.3)
 Tail 1 (4.3)
Tumor stage
 I 0 (0.0)
 II 6 (28.6)
 III 15 (71.4)
 IV 0 (0.0)
LN metastasis
 No 6 (26.1)
 Yes 17 (73.9)
PCDH10 methylation status
 Low 16 (69.6)
 High 7 (30.4)
Tumor progression
 No 8 (34.8)
 Yes 15 (65.2)
Occurrence of death
 No 5 (21.7)
 Yes 18 (78.3)